DMOA Co., Ltd

As of March 31, 2026, DMOA Co., Ltd carries a market capitalization of 40.80B, placing it among publicly traded companies globally. Its enterprise value stands at -21.01B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2026, DMOA Co., Ltd has 10.19M shares outstanding.

As of March 31, 2026, DMOA Co., Ltd trades at a trailing price-to-earnings ratio of 1.75. The price-to-sales ratio is 1.01, and the price-to-book ratio stands at 0.44.

As of March 31, 2026, DMOA Co., Ltd maintains a current ratio of 2.14, meaning it holds 2.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 3.70, indicating elevated leverage, while an interest coverage ratio of 4.38 demonstrates adequate ability to service its debt obligations.

Over the twelve months ended March 31, 2026, DMOA Co., Ltd posted a return on equity (ROE) of 18.21, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 4.95 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 11.07, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 18.74, useful for judging operating efficiency across full business cycles. The company generates approximately 133.12M in revenue per employee across its workforce of 184.50, a quick read on workforce productivity versus industry peers.

Over the twelve months ended March 31, 2026, DMOA Co., Ltd recorded 3.80B in income tax expense. That works out to an effective tax rate of 24.00, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 15.83B, leaving 14.23B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 23, 2026, DMOA Co., Ltd's stock has declined approximately 61.66% over the past 52 weeks. The 50-day moving average sits at 2,482.30, while the 200-day moving average is 3,291.08.

Over the twelve months ended March 31, 2026, DMOA Co., Ltd generated 24.56B in revenue and converted that into 14.23B in net income, yielding earnings per share of 1,893.04. EBITDA reached 6.45B, while operating income came in at 5.41B.

As of March 31, 2026, DMOA Co., Ltd holds 65.28B in cash and equivalents against 3.47B in total debt, resulting in a net debt position of -47.91B. Total book value stands at 93.76B, with working capital of 60.90B providing operational flexibility.

These figures cover the twelve months ended March 31, 2026.

Over the twelve months ended March 31, 2026, DMOA Co., Ltd posted a gross margin of 98.58, reflecting its pricing power and cost economics. The operating margin of 22.03 and net profit margin of 57.93 provide insight into operational efficiency.

DMOA Co., Ltd's most recent stock split took place on May 17, 2024 with a 30:1 split ratio.

As of March 31, 2026, DMOA Co., Ltd has an Altman Z-Score of 1.37, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.